The Shenzhen Stock Exchange announced on August 3 that the investigation by the China Securities Regulatory Commission found that Li Guojun, the chairman of Peking University Pharmaceuticals, learned during the period from June to mid-September 2013 that Zhengquan Holdings and Peking University Resources Holdings signed an equity holding agreement, but The company did not fulfill its disclosure obligations in a timely manner, and the then chairman Li Guojun failed to fulfill his duties and fulfill his duty of integrity and diligence. Therefore, he publicly condemned Peking University Medicine and then Chairman Li Guojun.
The Shenzhen Stock Exchange stated that it has been found that Peking University Medicine and related parties have the following violations:
From June to September 2013, Zhengquan Holdings and Peking University Resources Holdings signed the “Equity Holding Agreementâ€, stipulating that Zhengquan Holdings will hold 40 million shares of Peking University Pharmaceuticals for Peking University Resources Holdings. After the above agreement was signed, neither Peking University Resources Holdings nor Zhengquan Holdings had fulfilled its disclosure obligations in a timely manner regarding the agreement and the changes in its holdings of Peking University Pharmaceuticals.
According to the investigation conducted by the China Securities Regulatory Commission, Li Guojun, the then chairman of Peking University Pharmaceuticals, learned of the issue of equity holding agreement between Zhengquan Holdings and Peking University Resources Holdings during the period from June to mid-September 2013, but the company failed to fulfill its disclosure obligations in a timely manner.
The above behavior of Peking University Pharmaceuticals violates Articles 1.4, 2.1, 7.3, and 11.8.1 of the Stock Exchange Listing Rules (2012 Revision), and the Stock Listing Rules ( The provisions of Articles 1.4, 2.1, 7.3 and 11.8.1 of 2014 Revision).
Li Guojun, the then chairman of Peking University Pharmaceuticals, failed to fulfill his duties and fulfill his duties of integrity and diligence, in violation of Articles 1.4, 3.1.5 and 3.1.6 of the Stock Exchange Listing Rules (2012 Revision). Sections 1.4, 3.1.5 and 3.1.6 of the Rules Governing the Listing of Stocks (2014 Revision) and the “Guidelines for the Standard Operation of Listed Companies of Main Boards (developed in 2010)†The provisions of Article 3.3.23 are responsible for the above-mentioned violations of the company.
In view of the above-mentioned violations of facts and circumstances, in accordance with the provisions of Articles 17.2, 17.3 and 19.3 of the Stock Exchange Listing Rules (2014 Revision), the Disciplinary Committee of the Institute reviewed and approved The following disciplinary decisions were made:
1. Disciplinary action against Peking University Pharmaceutical Co., Ltd.;
2. The punishment for the public condemnation of Li Guojun, the then chairman of Peking University Pharmaceutical Co., Ltd.
The above-mentioned violations of Peking University Pharmaceutical Co., Ltd. and related parties and the penalties imposed by the Stock Exchange will be recorded in the integrity of the listed company and will be announced to the public.
Nano Stick Tape,Reusable Nano Tape,Traceless Adhesive Tape,Double Sided Gel Adhesive Tape
Kunshan Jieyudeng Intelligent Technology Co., Ltd. , https://www.jerrytapes.com